Company / Free Cash Flow
Coherus Oncology, Inc. Free Cash Flow History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$26.5M
FY2019
5-year range
-$204.9M / $26.5M
FY2015-FY2019
Trend
+116.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$205M to $27M over the past 2 years.
Based on SEC 10-K filings.
$27M in FY2019.
Improved from -$205M to $27M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, free cash flow increased 116.6% year-over-year.
- Lowest free cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $26.5M | +116.6% |
| FY2018 | -$160.1M | +21.9% |
| FY2017 | -$204.9M | -665.1% |
| FY2016 | -$26.8M | -277.9% |
| FY2015 | $15.1M | +175.1% |
| FY2014 | -$20.0M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026